Learn TPMT testing: Your Path to Safer, Smarter Treatment

TPMT testing is one of the best established gene tests in medicine, and it is often done before someone starts azathioprine, mercaptopurine or thioguanine. Below you will find the basics, plus a practical guide to test types, results, NUDT15, cost and next steps with your prescriber.

Introduction:

Ever ask yourself why a drug works for one but is toxic for another? Thiopurine S-Methyltransferase (TPMT), or TPMT for short, is a crucial factor in the way our bodies metabolize certain drugs. We will discuss what TPMT testing is and how RPH Lab’s home PGx testing kit can potentially be part of the solution to deliver safer, more effective personalized medicine solutions

What is Thiopurine S-Methyltransferase (TPMT)?

TPMT or Thiopurine S-Methyltransferase is an internal housekeeping enzyme responsible for metabolising azathioprine, 6-mercaptopurine (6-MP) and 6-thioguanine (6-TG) that are used for inflammatory bowel disease (IBD), acute lymphoblastic leukaemia (ALL), and organ transplantation. Your TPMT gene determines the efficiency of its activity, but variation in genetics can influence its function, thus changing the impact and the interactions of all these medicines on your system.

The Importance of TPMT Testing

TPMT testing is an integral component of pharmacogenomics (PGx), in which a patient’s DNA is employed to guide therapy. TPMT activity is not only crucial for avoiding side effects but also for optimizing drug effect. By understanding a patient’s TPMT enzyme activity, healthcare providers can adjust medication dosages more precisely. This personalised approach enhances safety and effectiveness in treatment plans.

Preventing Adverse Drug Reactions: How Can We Limit Their Impact

Some individuals possess genetic polymorphisms in their TPMT gene that interfere with its enzyme’s proper function, leading to build-ups of thiopurine drugs in your system and myelosuppression, where your bone marrow produces fewer blood cells and poses greater risks like infections. TPMT testing helps lower these risks by letting doctors adjust doses or pick safer drugs.

Optimizing Drug Efficacy

If your TPMT enzyme is working normally, standard doses of thiopurine drugs usually work great. TPMT testing confirms this, so your doctor can give you just the right amount to manage your condition effectively. It’s all about getting the best results with the least risk.

Genetic Variants of TPMT

Your TPMT gene may contain variations, such as TPMT 2, TPMT 3A, TPMT 3B or TPMT 3C that decrease its activity. About 10% of people carry one variant (heterozygous), leading to moderate activity, and about 0.3% carry two variants (homozygous), with no or minimal activity.

These variants are more likely to have serious side effects with normal doses.

TPMT Type	How common	Enzyme level	What it Means
TPMT *1/*1 (Normal)	About 89% (Normal)	Normal	Standard doses are okay
TPMT *1/*2, *1/*3A, etc. (Heterozygous)	About 10% (Moderate)	Moderate	May need lower doses
TPMT *3A/*3A, *2/*3A, etc. (Homozygous)	About 0.3% (Very low/none)	Very low /None	High risk; another drug may be better

Clinical Applications of TPMT Testing

TPMT testing is used in multiple medical fields to ensure the efficacy and safety of thiopurine medications via personalized dosing.

• Inflammatory Bowel Disease (IBD)

In IBD cases such as Crohn’s disease and ulcerative colitis, azathioprine and 6-mercaptopurine are used for their anti-inflammatory effects. TPMT testing identifies patients sensitive to myelosuppression, enabling dose alteration or switching to other therapies.

• Acute Lymphoblastic Leukaemia (ALL)

In ALL, 6-mercaptopurine helps keep cancer in check. TPMT testing ensures the dose is safe, avoiding toxicity while fighting the disease.

• Organ Transplantation

Thiopurine drugs prevent organ transplant rejection. TPMT testing helps doctors fine-tune doses, reducing side effects and helping the transplant succeed.

The Role of Pharmacogenomics (PGx)

Pharmacogenomics (PGx) is all about using your DNA to pick the right drugs and doses. By checking genetic variants like those in the TPMT gene, PGx testing makes treatment more precise, moving us toward personalized medicine. TPMT testing is a top example, with experts recommending it before starting thiopurine drugs.

At-Home PGx Testing with RPH Lab

RPH Lab makes personalized medicine easy with its at-home PGx testing kit. It checks your TPMT gene and other markers affecting how you process 240+ medications. Here’s how it works:

• Get Your Kit: Order it for $299 at RPH Labs.
• Take a Sample: Swab your cheek at home.Send It In: Use the prepaid envelope to mail it back.
• See Your Results: Get a clear report on your drug response, with lab support if you have questions.

RPH Lab is CLIA-certified, COLA-accredited, and HIPAA-compliant, so your results are accurate and private. The report is easy to share with your doctor for better treatment plans.

Who should consider TPMT testing?

The FDA labels for azathioprine, mercaptopurine and thioguanine all discuss TPMT status, and the labels for azathioprine and mercaptopurine recommend considering testing before treatment. In practice, the test is most useful for people who are about to start one of the thiopurine drugs, or who already take one and have had unexplained low blood counts.

You might hear about it if you have:

• Crohn’s disease or ulcerative colitis and your gastroenterologist is planning azathioprine or mercaptopurine
• Rheumatoid arthritis, lupus, autoimmune hepatitis or another autoimmune condition treated with azathioprine
• A kidney transplant and a regimen that includes azathioprine
• A child with acute lymphoblastic leukemia, where mercaptopurine is part of long-term treatment
• Severe low white cell counts on a thiopurine in the past

Testing ahead of time is ideal, because the result can shape the very first dose. Your genes never change, so a result from years ago still applies if you need one of these medicines again later.

Children are a special case. In childhood leukemia, mercaptopurine is often taken daily for many months, so the right dose matters for both safety and keeping the cancer in remission. Pediatric cancer teams commonly check TPMT and NUDT15 status early in treatment and then adjust doses based on blood counts over time.

Genotype test vs TPMT enzyme activity test

There are two ways to check TPMT status. They look at the same question from different angles, and each has strengths.

TPMT genotype

A genotype test reads your DNA to find known variants such as TPMT*2, *3A and *3C. It can be done from a cheek swab, saliva or blood. The result is not affected by blood transfusions or by drugs you are taking. The limitation is that it only finds the variants it looks for, so a rare variant could be missed.

TPMT enzyme activity (phenotype)

A phenotype test measures TPMT enzyme activity directly in a blood sample. It can pick up low activity even when the cause is a rare variant. However, a transfusion in the previous few months can give a falsely normal result, because the donor’s red cells carry their own enzyme. Some medicines can also affect the reading.

Many clinics use one or the other, and some use both when a result seems out of line with how a patient is doing. Neither test replaces regular blood count checks during treatment.

What TPMT deficiency means for your body

TPMT deficiency means your body has low or absent TPMT enzyme activity, usually because you inherited reduced-function variants from both parents. People with one reduced-function copy have intermediate activity rather than full deficiency.

TPMT deficiency does not cause symptoms by itself. You would not know you have it in daily life. It only matters when you take thiopurine drugs, because the enzyme is one of the main ways your body inactivates them.

Without enough TPMT, more of the drug is turned into active thioguanine nucleotides. At a standard dose that can lead to severe, sometimes life-threatening bone marrow suppression, with very low white cells, red cells and platelets. That is why the result matters so much before the first dose rather than after problems appear.

The good news is that knowing about TPMT deficiency ahead of time lets your care team choose another treatment or use a much smaller dose with close monitoring. The information turns a hidden risk into a planned decision.

Why NUDT15 testing matters alongside TPMT

TPMT is not the whole story. A second gene, NUDT15, also helps clear the active forms of thiopurine drugs. Reduced NUDT15 function leads to the same kind of bone marrow toxicity as TPMT deficiency.

NUDT15 testing is especially important for people of East Asian or Hispanic ancestry, where reduced-function NUDT15 variants are more common and TPMT variants are less common. A person could have a completely normal TPMT result and still be at high risk because of NUDT15.

The Clinical Pharmacogenetics Implementation Consortium updated its thiopurine guidance to include both genes. You can read it on the CPIC guidelines page. If you only have a TPMT result, it is reasonable to ask your prescriber whether NUDT15 testing should be added.

The RPh Labs panel reports both TPMT and NUDT15 from the same cheek swab, so you do not need a second sample.

Reading your TPMT testing report

Most reports show your genotype as two star alleles, one from each parent, followed by a phenotype. Here is how to read it:

• *1/*1, normal metabolizer: usual TPMT enzyme activity. Standard starting doses are generally appropriate.
• One reduced-function allele, such as *1/*3A, intermediate metabolizer: guidelines suggest starting at a reduced dose and adjusting based on blood counts.
• Two reduced-function alleles, such as *3A/*3A, poor metabolizer: for non-cancer conditions, guidelines suggest considering a different drug. For cancer treatment, a drastically reduced dose with frequent monitoring may be used.
• Possible intermediate or indeterminate: the combination is uncommon or includes an allele of uncertain function. Your prescriber or pharmacist can help interpret it.

Your report will list TPMT and NUDT15 separately, and both need to be considered together. MedlinePlus has a plain-language overview of the TPMT gene if you want more background.

Do not change or stop a medication based on your report alone. Bring it to the prescriber who manages your thiopurine.

Limits of TPMT testing you should know

A gene test is powerful, but it is not a guarantee. It is worth understanding what it can and cannot tell you.

• It does not replace blood counts. Low counts can still happen with normal TPMT and NUDT15 results, from infection, other drugs or the illness itself.
• It does not predict every side effect. Problems such as pancreatitis, nausea or liver changes are not explained by TPMT status.
• Drug interactions still matter. Allopurinol and febuxostat block a different breakdown pathway and can raise thiopurine levels whatever your genes show. Some aminosalicylates may also inhibit TPMT.
• Rare variants can be missed by a genotype test that only checks common alleles.

Your care team will combine your gene results with your age, kidney and liver function, other medications and your blood results. The test makes their decisions better informed, but it is one input among several.

Cost and insurance for TPMT testing

When a specialist orders a single-gene TPMT test before starting a thiopurine, many insurance plans cover it because it is tied to a specific prescription decision. Coverage varies, so check with your plan before the sample is taken, and ask whether the lab is in network.

Another route is a broader pharmacogenomic panel that includes TPMT along with other genes. The RPh Labs at-home kit covers 20 genes, including TPMT and NUDT15, and is reported against more than 240 medications. The self-pay price is $299, it is HSA and FSA eligible, and shipping is free both ways. RPh Labs also accepts insurance including Medicare, Texas Medicaid and Blue Cross Blue Shield of Texas. See the insurance page for details.

A panel can be useful if you also take or may need other medicines, such as antidepressants, blood thinners or statins, because the same result can be reused for years. For a single urgent decision, your specialist’s usual lab may be faster.

How to talk to your prescriber about thiopurine drugs

Coming prepared helps you and your prescriber make a shared plan. Useful questions include:

1. Has my TPMT status been checked, and has NUDT15 testing been done too?
2. Based on my results, what starting dose do you plan to use?
3. How often will my blood counts and liver tests be checked?
4. Are any of my other medicines, such as allopurinol, likely to interact?
5. What symptoms should make me call you right away?

If you order your own test, bring a copy of the report to the appointment. Every RPh Labs report is reviewed by a PharmD pharmacist, and a free pharmacist consultation is included if you want help understanding it first. You can also browse the medication list by gene to see which other drugs your results may affect.

Finally, keep a copy of your results somewhere easy to find, such as a phone photo or your patient portal. Share them with any new specialist, pharmacist or hospital team. Because the result never changes, it can prevent the same question from being asked again, and it gives every prescriber the same starting point.

Conclusion

TPMT testing is a powerful tool in personalised medicine, helping you avoid side effects and get the most from thiopurine drugs for IBD, ALL, or organ transplantation. Knowing your TPMT status means safer, more effective treatment tailored to you. RPH Lab’s at-home PGx testing kit makes it simple to get these insights from home. Don’t guess with your health—visit RPH Labs today to order your kit and start your journey to smarter, safer care.

TPMT testing FAQ

Is TPMT testing a blood test or a cheek swab?

It can be either. A genotype test reads your DNA, so it can use a cheek swab, saliva or blood. A TPMT enzyme activity test measures the enzyme itself and needs a blood sample. Your prescriber may prefer one type depending on your history, such as a recent blood transfusion.

How common is TPMT deficiency?

Complete TPMT deficiency, meaning two reduced-function copies of the gene, is rare. Having one reduced-function copy, which gives intermediate activity, is much more common. Frequencies differ between populations, which is one reason guidelines favor testing before treatment rather than guessing based on background.

Can a blood transfusion affect my TPMT result?

It can affect an enzyme activity test, because donor red blood cells bring their own TPMT enzyme and can make low activity look normal for a few months. A genotype test is not affected, because it reads your own DNA rather than measuring enzyme in the blood.

Which thiopurine drugs does the result apply to?

TPMT and NUDT15 results apply to azathioprine, mercaptopurine and thioguanine. Azathioprine is converted into mercaptopurine in the body, so the same enzymes handle all three. One result covers all of them, now and in the future.

Do I still need NUDT15 testing if my TPMT result is normal?

It is a good idea. NUDT15 variants cause similar bone marrow toxicity and are more common in some populations, including people of East Asian and Hispanic ancestry. A normal TPMT result does not tell you anything about NUDT15, so ask your prescriber whether both genes have been checked.

How long do TPMT results take?

It depends on the lab. With the RPh Labs at-home kit, results are ready 7 to 10 business days after the sample reaches the lab, and each report is reviewed by a PharmD pharmacist before release. Hospital labs may offer faster turnaround for urgent treatment decisions.